Purchase Order HT001425P0034
Award Date
2/28/25
Potential Completion Date
2/27/30
Potential Value
$224K
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency (DHA) has awarded a $76,200 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for adaptive immunosequencing services. The award does not have a set-aside designation. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products. The company has previously received awards from the Department of Health and Human Services (HHS) and Department of Veterans Affairs (VA) to provide...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Adaptive Biotechnologies Corporation, doing business as Adaptive, to provide ClonoSEQ minimal residual disease testing services for the Boston and West Haven VA health care systems. The contract has a ceiling value of $95,000.00 and a period of performance through July 2026. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products, and...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Adaptive Biotechnologies Corporation, doing business as Adaptive, for ClonoSEQ minimal residual disease testing services. The $165,700 contract has a performance period ending July 14, 2025 and is a call under a larger $828,750 single award blanket purchase agreement (BPA) from the VA's Veterans Integrated Service Network 1 for ClonoSEQ services benefiting VA medical...
This is a $6,000 firm fixed price contract awarded by the Veterans Integrated Service Network 1 (VISN 1) of the Department of Veterans Affairs to Adaptive Biotechnologies Corporation, doing business as Adaptive, to provide ClonoSEQ minimal residual disease testing services. The contract is a call under a $828,750 single award blanket purchase agreement (BPA) with the VA's Veterans Health Administration, with two prior calls totaling $331,500 for ClonoSEQ services at VA medical facilities in...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Adaptive Biotechnologies Corporation, doing business as Adaptive, for ClonoSEQ minimal residual disease testing services. The contract, with a ceiling value of $9,750.00, is a call under a $828,750.00 single award blanket purchase agreement held by Adaptive with the VA's Veterans Integrated Service Network 1 for a 5-year ordering period ending in July 2027. The contract supports VA medical facilities in the...
This is a firm fixed price purchase order valued at $234,900.00 awarded by the National Institutes of Health (NIH) Clinical Center to Adaptive Biotechnologies Corporation, doing business as Adaptive, with a period of performance ending on September 30, 2024. The contract does not have a set-aside designation. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products, including immunosequencing, DNA extraction, and COVID-19 research services for the...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Adaptive Biotechnologies Corporation (also doing business as Adaptive) for IMMUNOSEQ MMTCRB SERVICE. The contract, valued at $12,200.00, does not have a set-aside designation. Through this award, Adaptive Biotechnologies will provide specialized sequencing and testing services to support HHS research programs. Adaptive...
This contract award from the Department of Health and Human Services Food and Drug Administration is for the purchase of laboratory equipment by Adaptive Biotechnologies Corporation, doing business as Adaptive. The $126,152.20 firm fixed price purchase order was set aside for small businesses and awarded on September 11, 2019 with a completion date of October 10, 2019. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products, including specialized testing...
This is a $90,624.80 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Adaptive Biotechnologies Corporation (Adaptive) for the provision of Adaptive Biotechnologies kits. The contract has a completion date of October 30, 2020. Adaptive is a commercial provider of immune-driven medicine services and products, and this award supports the company's provision of specialized testing and genomic sequencing services to the FDA. The...
Adaptive Biotechnologies Corporation, doing business as Adaptive, has been awarded a firm fixed price purchase order valued at thirteen thousand four hundred dollars from the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, Adaptive will provide immunosequencing and laboratory testing services in support of the agency's research programs. Specifically, Adaptive will deliver T-cell receptor beta...